Economic Evaluation in Duchenne Muscular Dystrophy: Model Frameworks for Cost-Effectiveness Analysis

BACKGROUND: Several treatments are on the horizon for Duchenne muscular dystrophy (DMD), a terminal orphan disease. In many jurisdictions, decisions regarding pricing and reimbursement of these health technologies comprise evidence of value for money. OBJECTIVE: The objective of this study was to de...

Descripción completa

Detalles Bibliográficos
Autores principales: Landfeldt, Erik, Alfredsson, Lars, Straub, Volker, Lochmüller, Hanns, Bushby, Katharine, Lindgren, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253157/
https://www.ncbi.nlm.nih.gov/pubmed/27798808
http://dx.doi.org/10.1007/s40273-016-0461-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253157/
https://www.ncbi.nlm.nih.gov/pubmed/27798808
http://dx.doi.org/10.1007/s40273-016-0461-5

Ejemplares similares